TY  - GEN 
AU  - Loche, Sandro
AU  - Kanumakala, Shankar
AU  - Backeljauw, Philippe
AU  - Schwab, Karl Otfried
AU  - Lechuga Sancho, Alfonso María
AU  - Esmael, Altaher
AU  - Urosevic, Dragan
AU  - Boldea, Anca
AU  - Zabransky, Markus
A4  - Materno-Infantil y Radiología
PY  - 2024
SN  - 1177-8881
UR  - http://hdl.handle.net/10498/32750
AB  - Purpose: Omnitrope® (somatropin) was approved as a biosimilar recombinant human growth hormone (rhGH) in 2006. Here, we
report final data from the PAtients TReated with Omnitrope® (PATRO) Children study, a post-marketing surveillance study designed...
LA  - eng
PB  - Dovepress
KW  - Omnitrope
KW  - PATRO Children
KW  - growth hormone
KW  - pediatrics
KW  - growth hormone deficiency
KW  - small for gestational age
TI  - Safety and Effectiveness of a Biosimilar Recombinant Human Growth Hormone in Children Requiring Growth Hormone Treatment: Analysis of Final Data from PATRO Children, an International, Post-Marketing Surveillance Study
DO  - https://doi.org/10.2147/DDDT.S440009
ER  -